Biocon Biologics

Biocon Biologics is a global biosimilars company on a mission to make lifesaving, life-changing biologics affordable and accessible for all. Our therapies, including insulins and monoclonal antibodies, are transforming lives across the world — from New York to Nairobi to New Delhi — by treating chronic conditions like diabetes, cancer, autoimmune, and eye diseases.

Backed by cutting-edge science, deep R&D, mega-scale manufacturing, and global regulatory expertise, we’re setting new standards in affordable biologics across the U.S., Europe, Japan, Canada, Australia, and Emerging Markets.

We believe healthcare is a right, not a privilege. Subscribe to follow our journey — as we innovate, inspire, and expand access, one biosimilar at a time.